These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34301276)

  • 1. A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation.
    Maio M; Lahn M; Di Giacomo AM; Covre A; Calabrò L; Ibrahim R; Fox B;
    J Exp Clin Cancer Res; 2021 Jul; 40(1):240. PubMed ID: 34301276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy.
    Maio M; Coukos G; Ferrone S; Fox BA; Fridman WH; Garcia PL; Lahn M; Provendier O; Russo V; Rüttinger D; Shalabi A; Trajanoski Z; Viallet J; Wolchok JD; Ibrahim R
    Cancer Immunol Immunother; 2019 Jan; 68(1):1-9. PubMed ID: 30564889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology.
    Di Giacomo AM; Covre A; Giacobini G; Ibrahim R; Lyman J; Natali PG; Maio M
    Cancer Immunol Immunother; 2019 Jan; 68(1):143-150. PubMed ID: 30564888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT).
    Russo V; Amadori A; Bregni M; Calabrò L; Colombo MP; Di Nicola M; Ferrucci PF; Proietti E; Maio M; Bellone M
    Cytokine Growth Factor Rev; 2017 Aug; 36():1-3. PubMed ID: 28634022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5-7, 2017.
    Maio M; Lofiego MF; Fazio C; Cannito S; Chiarucci C; Giacobini G; Valente M; Tunici P; Covre A; Russo V
    Cancer Immunol Immunother; 2019 Jan; 68(1):151-158. PubMed ID: 30094463
    [No Abstract]   [Full Text] [Related]  

  • 6. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?
    Di Giacomo AM; Lahn M; Eggermont AM; Fox B; Ibrahim R; Sharma P; Allison JP; Maio M
    Eur J Cancer; 2024 Feb; 198():113501. PubMed ID: 38169219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancer.
    Maio M; Nicolay HJ; Ascierto PA; Belardelli F; Camerini R; Colombo MP; Queirolo P; Ridolfi R; Russo V; Parisi G; Fonsatti E; Papamichail M; Parmiani G;
    Cancer Immunol Immunother; 2012 Sep; 61(9):1599-608. PubMed ID: 22736255
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!
    Maio M; Blank C; Necchi A; Di Giacomo AM; Ibrahim R; Lahn M; Fox BA; Bell RB; Tortora G; Eggermont AMM
    Eur J Cancer; 2021 Jul; 152():155-164. PubMed ID: 34107449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second- and third-generation drugs for immuno-oncology treatment-The more the better?
    Dempke WCM; Fenchel K; Uciechowski P; Dale SP
    Eur J Cancer; 2017 Mar; 74():55-72. PubMed ID: 28335888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.
    Bellone M; Brevi A; Bruzzì S; Consonni M; De Santis F; Di Lullo G; Majorini MT; Pastò A; Amadori A; Bregni M; Di Nicola M; Calabrò L; Ferrucci PF; Proietti E; Colombo MP; Russo V
    Cancer Immunol Immunother; 2020 Jun; 69(6):1141-1151. PubMed ID: 32025818
    [No Abstract]   [Full Text] [Related]  

  • 12. The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.
    Pennock GK; Chow LQ
    Oncologist; 2015 Jul; 20(7):812-22. PubMed ID: 26069281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for brain metastases and primary brain tumors.
    Di Giacomo AM; Mair MJ; Ceccarelli M; Anichini A; Ibrahim R; Weller M; Lahn M; Eggermont AMM; Fox B; Maio M
    Eur J Cancer; 2023 Jan; 179():113-120. PubMed ID: 36521332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010.
    Maio M; Nicolay HJ; Ascierto PA; Belardelli F; Camerini R; Colombo MP; Queirolo P; Ridolfi R; Russo V; Fonsatti E; ; Parmiani G
    Cancer Immunol Immunother; 2011 Jun; 60(6):901-7. PubMed ID: 21431916
    [No Abstract]   [Full Text] [Related]  

  • 16. The Italian Network for Tumor Biotherapy (NIBIT). Sharing visions, goals and efforts at European level.
    Maio M; Fonsatti E; Burigo A; Parmiani G
    Tumori; 2008; 94(2):179-81. PubMed ID: 18564604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-oncology-101: overview of major concepts and translational perspectives.
    Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, Italy.
    Bellone M; Bregni M; Bronte V; Ugel S; Ferrucci PF; Di Nicola M; Nisticò P; Zuccolotto G; Rosato A; Russo V; Sica A; Colombo MP
    Cancer Immunol Immunother; 2022 Jul; 71(7):1777-1786. PubMed ID: 34755203
    [No Abstract]   [Full Text] [Related]  

  • 20. Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
    Chuntova P; Chow F; Watchmaker PB; Galvez M; Heimberger AB; Newell EW; Diaz A; DePinho RA; Li MO; Wherry EJ; Mitchell D; Terabe M; Wainwright DA; Berzofsky JA; Herold-Mende C; Heath JR; Lim M; Margolin KA; Chiocca EA; Kasahara N; Ellingson BM; Brown CE; Chen Y; Fecci PE; Reardon DA; Dunn GP; Liau LM; Costello JF; Wick W; Cloughesy T; Timmer WC; Wen PY; Prins RM; Platten M; Okada H
    Neuro Oncol; 2021 Mar; 23(3):356-375. PubMed ID: 33367885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.